Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 4064156, 9 pages
https://doi.org/10.1155/2017/4064156
Research Article

Tangshen Formula Attenuates Colonic Structure Remodeling in Type 2 Diabetic Rats

1Beijing Key Lab for Immune-Mediated Inflammatory Diseases, Institute of Clinical Medical Science, China-Japan Friendship Hospital, Beijing, China
2Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
3Department of Combination of Traditional Chinese and Western Medicine, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China

Correspondence should be addressed to Ping Li; moc.361@5768pl

Received 6 June 2016; Accepted 26 December 2016; Published 20 February 2017

Academic Editor: Onesmo B. Balemba

Copyright © 2017 Pengmin Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. S. Yarandi and S. Srinivasan, “Diabetic gastrointestinal motility disorders and the role of enteric nervous system: current status and future directions,” Neurogastroenterology and Motility, vol. 26, no. 5, pp. 611–624, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. J.-H. Oh, M.-G. Choi, M.-I. Kang et al., “The prevalence of gastrointestinal symptoms in patients with non-insulin dependent diabetes mellitus,” Korean Journal of Internal Medicine, vol. 24, no. 4, pp. 309–317, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. J. H. Kim, H. S. Park, S. Y. Ko et al., “Diabetic factors associated with gastrointestinal symptoms in patients with type 2 diabetes,” World Journal of Gastroenterology, vol. 16, no. 14, pp. 1782–1787, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. F. L. Iber, S. Parveen, M. Vandrunen et al., “Relation of symptoms to impaired stomach, small bowel, and colon motility in long-standing diabetes,” Digestive Diseases and Sciences, vol. 38, no. 1, pp. 45–50, 1993. View at Publisher · View at Google Scholar · View at Scopus
  5. H.-K. Jung, D.-Y. Kim, I.-H. Moon, and Y.-S. Hong, “Colonic transit time in diabetic patients—comparison with healthy subjects and the effect of autonomic neuropathy,” Yonsei Medical Journal, vol. 44, no. 2, pp. 265–272, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Forrest and M. Parsons, “The enhanced spontaneous activity of the diabetic colon is not the consequence of impaired inhibitory control mechanisms,” Autonomic and Autacoid Pharmacology, vol. 23, no. 3, pp. 149–158, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. M. A. Sims, W. L. Hasler, W. D. Chey, M. S. Kim, and C. Owyang, “Hyperglycemia inhibits mechanoreceptor-mediated gastrocolonic responses and colonic peristaltic reflexes in healthy humans,” Gastroenterology, vol. 108, no. 2, pp. 350–359, 1995. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Wu, C. K. Rayner, R. L. Young, and M. Horowitz, “Gut motility and enteroendocrine secretion,” Current Opinion in Pharmacology, vol. 13, no. 6, pp. 928–934, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Siegman, M. Eto, and T. M. Butler, “Remodeling of the rat distal colon in diabetes: function and ultrastructure,” American Journal of Physiology—Cell Physiology, vol. 310, no. 2, pp. C151–C160, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Chen, J. Zhao, and H. Gregersen, “Up-regulated expression of advanced glycation end-products and their receptor in the small intestine and colon of diabetic rats,” Digestive Diseases and Sciences, vol. 57, no. 1, pp. 48–57, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. P. M. Chen, H. Gregersen, and J. B. Zhao, “Advanced glycation end-product expression is upregulated in the gastrointestinal tract of type 2 diabetic rats,” World Journal of Diabetes, vol. 6, no. 4, pp. 662–672, 2015. View at Google Scholar
  12. J. Zhao, P. Chen, and H. Gregersen, “Morpho-mechanical intestinal remodeling in type 2 diabetic GK rats—is it related to advanced glycation end product formation?” Journal of Biomechanics, vol. 46, no. 6, pp. 1128–1134, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. N. G. Cruz, L. P. Sousa, M. O. Sousa, N. T. Pietrani, A. P. Fernandes, and K. B. Gomes, “The linkage between inflammation and Type 2 diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 99, no. 2, pp. 85–92, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Zhang, P. Li, F. J. Burczynski et al., “Attenuation of diabetic nephropathy in Otsuka Long-Evans Tokushima Fatty (OLETF) rats with a combination of Chinese herbs (Tangshen Formula),” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 613737, 8 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Zhao, S. Sun, H. Zhang et al., “Therapeutic effects of tangshen formula on diabetic nephropathy in rats,” PLoS ONE, vol. 11, no. 1, Article ID e0147693, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Li, Y. Chen, J. Liu et al., “Efficacy and safety of tangshen formula on patients with type 2 diabetic kidney disease: a multicenter double-blinded randomized placebo-controlled trial,” PLoS ONE, vol. 10, no. 5, Article ID e0126027, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Zhao, P. Chen, and H. Gregersen, “Stress-strain analysis of jejunal contractility in response to flow and ramp distension in type 2 diabetic GK rats: effect of carbachol stimulation,” Journal of Biomechanics, vol. 46, no. 14, pp. 2469–2476, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. F. L. Iber, S. Parveen, M. Vandrunen et al., “Relation of symptoms to impaired stomach, small bowel, and colon motility in long-standing diabetes,” Digestive Diseases and Sciences, vol. 38, no. 1, pp. 45–50, 1993. View at Publisher · View at Google Scholar · View at Scopus
  19. Q. Li and I. M. Verma, “NF-κB regulation in the immune system,” Nature Reviews Immunology, vol. 2, no. 10, pp. 725–734, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Hanada and A. Yoshimura, “Regulation of cytokine signaling and inflammation,” Cytokine and Growth Factor Reviews, vol. 13, no. 4-5, pp. 413–421, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Zhao, B. Krishnamurthy, Z. U. A. Mollah, T. W. H. Kay, and H. E. Thomas, “NF-κB in type 1 diabetes,” Inflammation and Allergy—Drug Targets, vol. 10, no. 3, pp. 208–217, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. S. R. Shiou, Y. Yu, Y. Guo et al., “Oral administration of transforming growth factor-beta1 (TGF-beta1) protects the immature gut from injury via Smad protein-dependent suppression of epithelial nuclear factor kappaB (NF-kappaB) signaling and proinflammatory cytokine production,” The Journal of Biological Chemistry, vol. 288, no. 48, pp. 34757–34766, 2013. View at Google Scholar
  23. K. L. Howe, C. Reardon, A. Wang, A. Nazli, and D. M. McKay, “Transforming growth factor-β regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O157:H7-induced increased permeability,” American Journal of Pathology, vol. 167, no. 6, pp. 1587–1597, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. N. A. Hering, S. Andres, A. Fromm et al., “Transforming growth factor-β, a whey protein component, strengthens the intestinal barrier by upregulating claudin-4 in HT-29/B6 cells,” Journal of Nutrition, vol. 141, no. 5, pp. 783–789, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. B. van't Land, H. P. Meijer, J. Frerichs et al., “Transforming Growth Factor-β2 protects the small intestine during methotrexate treatment in rats possibly by reducing stem cell cycling,” British Journal of Cancer, vol. 87, no. 1, pp. 113–118, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Martin-Martin, C. Slattery, T. McMorrow, and M. P. Ryan, “TGF-β1 mediates sirolimus and cyclosporine a-induced alteration of barrier function in renal epithelial cells via a noncanonical ERK1/2 signaling pathway,” American Journal of Physiology-Renal Physiology, vol. 301, no. 6, pp. F1281–F1292, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Suer, D. Ampasala, M. F. Walsh, and M. D. Basson, “Role of ERK/mTOR signaling in TGFβ-modulated focal adhesion kinase mRNA stability and protein synthesis in cultured rat IEC-6 intestinal epithelial cells,” Cell and Tissue Research, vol. 336, no. 2, pp. 213–223, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. B. A. Vallance, M. I. Gunawan, B. Hewlett et al., “TGF-β1 gene transfer to the mouse colon leads to intestinal fibrosis,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 289, no. 1, pp. G116–G128, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Ohga, K. Shikata, K. Yozai et al., “Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-κB activation,” American Journal of Physiology—Renal Physiology, vol. 292, no. 4, pp. F1141–F1150, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Yang, Z. Zeng, T. Wu, Z. Yang, B. Liu, and T. Lan, “Emodin attenuates high glucose-induced TGF-β1 and fibronectin expression in mesangial cells through inhibition of NF-κB pathway,” Experimental Cell Research, vol. 319, no. 20, pp. 3182–3189, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Gui, J. Huang, Y. Guo et al., “Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κB-mediated inflammatory genes expression,” Cytokine, vol. 61, no. 3, pp. 970–977, 2013. View at Publisher · View at Google Scholar · View at Scopus